| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.051 | 0.7 |